My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 391

    1.

    Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study.

    Shen J, Arnett DK, Parnell LD, Peacock JM, Lai CQ, Hixson JE, Tsai MY, Province MA, Straka RJ, Ordovas JM.

    Diabetes Care. 2008 May;31(5):910-5. Epub 2008 Feb 19.PMID: 18285551 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.

    Lai CQ, Arnett DK, Corella D, Straka RJ, Tsai MY, Peacock JM, Adiconis X, Parnell LD, Hixson JE, Province MA, Ordovas JM.

    Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1417-25. Epub 2007 Apr 12.PMID: 17431185 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.

    Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP, Cushman M, Bis JC, Zeng D, Lin D, Kuller LH, Nickerson DA, Psaty BM, Tracy RP, Reiner AP.

    JAMA. 2006 Dec 13;296(22):2703-11.PMID: 17164456 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.

    Foucher C, Rattier S, Flavell DM, Talmud PJ, Humphries SE, Kastelein JJ, Ayyobi A, Pimstone S, Frohlich J, Ansquer JC, Steiner G; DAIS investigators.

    Pharmacogenetics. 2004 Dec;14(12):823-9.PMID: 15608561 [PubMed - indexed for MEDLINE]Related articles

    5.

    Impact of genetic and environmental factors on hsCRP concentrations and response to therapeutic agents.

    Shen J, Ordovas JM.

    Clin Chem. 2009 Feb;55(2):256-64. Epub 2008 Dec 12. Review.PMID: 19074515 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study.

    Liu Y, Ordovas JM, Gao G, Province M, Straka RJ, Tsai MY, Lai CQ, Zhang K, Borecki I, Hixson JE, Allison DB, Arnett DK.

    Pharmacogenet Genomics. 2009 Feb;19(2):161-9.PMID: 19057464 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.

    Paik JK, Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Hyun YJ, Cho JR, Lee JH.

    Clin Chim Acta. 2007 May 1;380(1-2):68-74. Epub 2006 Nov 25.PMID: 17335789 [PubMed - indexed for MEDLINE]Related articles

    8.

    Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states.

    Perez-Martinez P, Corella D, Shen J, Arnett DK, Yiannakouris N, Tai ES, Orho-Melander M, Tucker KL, Tsai M, Straka RJ, Province M, Kai CS, Perez-Jimenez F, Lai CQ, Lopez-Miranda J, Guillen M, Parnell LD, Borecki I, Kathiresan S, Ordovas JM.

    Am J Clin Nutr. 2009 Jan;89(1):391-9. Epub 2008 Dec 3.PMID: 19056598 [PubMed - indexed for MEDLINE]Related articles

    9.

    Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey.

    Crawford DC, Sanders CL, Qin X, Smith JD, Shephard C, Wong M, Witrak L, Rieder MJ, Nickerson DA.

    Circulation. 2006 Dec 5;114(23):2458-65. Epub 2006 Nov 13.PMID: 17101857 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci.

    Wessel J, Moratorio G, Rao F, Mahata M, Zhang L, Greene W, Rana BK, Kennedy BP, Khandrika S, Huang P, Lillie EO, Shih PA, Smith DW, Wen G, Hamilton BA, Ziegler MG, Witztum JL, Schork NJ, Schmid-Schönbein GW, O'Connor DT.

    J Hypertens. 2007 Feb;25(2):329-43.PMID: 17211240 [PubMed - indexed for MEDLINE]Related articles

    11.

    Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome.

    Shen J, Arnett DK, Peacock JM, Parnell LD, Kraja A, Hixson JE, Tsai MY, Lai CQ, Kabagambe EK, Straka RJ, Ordovas JM.

    J Nutr. 2007 Aug;137(8):1846-51.PMID: 17634253 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP Level and arterial pulse wave velocity in healthy elderly Japanese.

    Morita A, Nakayama T, Doba N, Hinohara S, Soma M.

    Hypertens Res. 2006 May;29(5):323-31.PMID: 16832152 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of fenofibrate on the levels of high sensitivity C-reactive protein in dyslipidaemic hypertensive patients.

    Coban E, Ozdogan M, Yazicioglu G, Sari R.

    Int J Clin Pract. 2005 Apr;59(4):415-8. Erratum in: Int J Clin Pract. 2006 Jul;60(7):889. PMID: 15853856 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.

    Stancáková A, Baldaufová L, Javorský M, Kozárová M, Salagovic J, Tkác I.

    Physiol Res. 2006;55(5):483-90. Epub 2005 Dec 12.PMID: 16343038 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia.

    Koh KK, Han SH, Quon MJ, Yeal Ahn J, Shin EK.

    Diabetes Care. 2005 Jun;28(6):1419-24.PMID: 15920062 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Association between sequence variant of c.553 G > T in the apolipoprotein A5 gene and metabolic syndrome, insulin resistance, and carotid atherosclerosis.

    Chien KL, Hsu HC, Chen YC, Su TC, Lee YT, Chen MF.

    Transl Res. 2009 Sep;154(3):133-41. Epub 2009 Jul 9.PMID: 19665689 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate.

    Brouillette C, Bossé Y, Pérusse L, Gaudet D, Vohl MC.

    J Hum Genet. 2004;49(8):424-32. Epub 2004 Jul 13.PMID: 15249972 [PubMed - indexed for MEDLINE]Related articles

    18.

    Decrease in inflammatory cardiovascular risk markers in hyperlipidemic diabetic patients treated with fenofibrate.

    Wu TJ, Ou HY, Chou CW, Hsiao SH, Lin CY, Kao PC.

    Ann Clin Lab Sci. 2007 Spring;37(2):158-66.PMID: 17522372 [PubMed - indexed for MEDLINE]Related articles

    19.

    The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants.

    Lawlor DA, Harbord RM, Timpson NJ, Lowe GD, Rumley A, Gaunt TR, Baker I, Yarnell JW, Kivimäki M, Kumari M, Norman PE, Jamrozik K, Hankey GJ, Almeida OP, Flicker L, Warrington N, Marmot MG, Ben-Shlomo Y, Palmer LJ, Day IN, Ebrahim S, Smith GD.

    PLoS One. 2008 Aug 20;3(8):e3011.PMID: 18714384 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.

    Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney JF Jr, Wilson PW, Newton-Cheh C, Musone SL, Camargo AL, Drake JA, Levy D, O'Donnell CJ, Hirschhorn JN, Benjamin EJ.

    Circulation. 2006 Mar 21;113(11):1415-23. Epub 2006 Mar 13.PMID: 16534007 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity